One proposed mechanism is related to the observation that patients with post-RYGB hypoglycemia have significantly higher levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), both of which exert a hypertrophic effect on the pancreatic islet cells. The gene discussed is GLP1R; the disease is Hypoglycemia.